SCHEMBL6419728

SCHEMBL6419728

COc1cc(Nc2ncc(-c3ccc4c(C)n[nH]c4c3)c(N)n2)cc(OC)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.49
AURKB Q96GD4 3/20 0.49
AURKA O14965 2/20 0.49
BRD4 O60885 1/20 0.44
PLK1 P53350 4/20 0.43
PTK2 Q05397 6/20 0.43
CDK2 P24941 3/20 0.42
PLK3 Q9H4B4 1/20 0.42
JAK2 O60674 2/20 0.42
SYK P43405 1/20 0.42
CYP3A4 P08684 1/20 0.42
JAK1 P23458 1/20 0.42
JAK3 P52333 1/20 0.42
CDK1 P06493 1/20 0.42
CDK4 P11802 1/20 0.42
CDK7 P50613 1/20 0.42
CDK9 P50750 1/20 0.42
EGFR P00533 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318895 0.80 IGF1R (0.59) KDRAURKBAURKAPTK2CDK2
SCHEMBL14634889 0.80 KDR (0.55) KDRAURKBAURKABRD4PLK1
SCHEMBL6317955 0.78 IGF1R (0.57) KDRAURKBAURKAPTK2CDK2
SCHEMBL2470494 0.78 KDR (0.53) KDRAURKBAURKABRD4PTK2
SCHEMBL6314234 0.77 KDR (0.57) KDRAURKBAURKAPTK2CDK2
SCHEMBL6311694 0.77 KDR (0.52) KDRAURKBAURKAPLK1PTK2
SCHEMBL14633767 0.77 KDR (0.49) KDRAURKBAURKABRD4PTK2
SCHEMBL2467117 0.76 KDR (0.51) KDRAURKBAURKABRD4PLK1
SCHEMBL27997729 0.76 FYN (0.59) KDRAURKBAURKAPLK1PTK2
Gw612286X SCHEMBL21067484 0.75 KDR (0.72) KDRAURKBAURKABRD4PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050118600-A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors F. HOFFMANN-LA ROCHE AG (CH) 2005-06-02 US claimed
EP-1483401-A1 METHOD FOR SELECTING DRUG SENSITIVITY-DETERMINING FACTORS AND METHOD FOR PREDICTING DRUG SENSITIVITY USING THE SELECTED FACTORS F.HOFFMANN-LA ROCHE AG (CH) 2004-12-08 EP claimed
WO-2003076660-A1 METHOD FOR SELECTING DRUG SENSITIVITY-DETERMINING FACTORS AND METHOD FOR PREDICTING DRUG SENSITIVITY USING THE SELECTED FACTORS F.HOFFMANN-LA ROCHE AG (CH) 2003-09-18 WO claimed
US-20050118600-A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors F. HOFFMANN-LA ROCHE AG (CH) 2005-06-02 US disclosed
EP-1483401-A1 METHOD FOR SELECTING DRUG SENSITIVITY-DETERMINING FACTORS AND METHOD FOR PREDICTING DRUG SENSITIVITY USING THE SELECTED FACTORS F.HOFFMANN-LA ROCHE AG (CH) 2004-12-08 EP disclosed
WO-2003076660-A1 METHOD FOR SELECTING DRUG SENSITIVITY-DETERMINING FACTORS AND METHOD FOR PREDICTING DRUG SENSITIVITY USING THE SELECTED FACTORS F.HOFFMANN-LA ROCHE AG (CH) 2003-09-18 WO disclosed